Nephros (NEPH) Return on Capital Employed Growth (3y) (2014 - 2026)
Nephros (NEPH) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 500.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 119.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 809.00 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 628.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -82.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 5.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1,708.00 |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 4,306.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,306.00 |
| Mar 31, 2026 | 3,845.00 |
| Dec 31, 2025 | 5,517.00 |
| Sep 30, 2025 | 5,169.00 |
| Jun 30, 2025 | 4,264.00 |
| Mar 31, 2025 | 3,595.00 |
| Dec 31, 2024 | 2,390.00 |
| Sep 30, 2024 | 1,282.00 |
| Jun 30, 2024 | 926.00 |
| Mar 31, 2024 | 1,006.00 |
| Dec 31, 2023 | 1,032.00 |
| Sep 30, 2023 | 981.00 |
| Jun 30, 2023 | -415.00 |
| Mar 31, 2023 | -811.00 |
| Dec 31, 2022 | -1,001.00 |
| Sep 30, 2022 | 382.00 |
| Jun 30, 2022 | 1,421.00 |
| Mar 31, 2022 | 1,592.00 |
| Dec 31, 2021 | 1,732.00 |
| Sep 30, 2021 | 1,751.00 |